Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000445
Filing Date
2024-06-24
Accepted
2024-06-24 16:11:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2969
  Complete submission text file 0001971857-24-000445.txt   4429
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-23186 | Film No.: 241064400
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4505 EMPEROR BLVD SUITE 200 DURHAM NC 27703
Business Address
McKee Amy E (Reporting) CIK: 0001883764 (see all company filings)

Type: 144